Abstract
Global cerebral ischemia (GCI) is a devastating condition characterized by neurological deficits and delayed neuronal apoptosis. This study investigates the neuroprotective effects of calcitriol, the active metabolite of Vitamin D, in a rat model of GCI. By activating the nuclear Vitamin D receptor (VDR) and the downstream ERK1/2 signaling pathway, calcitriol treatment was found to attenuate brain edema, reduce infarct volume, and improve functional recovery. These findings suggest that calcitriol-mediated VDR activation represents a potential therapeutic strategy for acute brain injury.
Introduction
Global cerebral ischemia (GCI), often resulting from cardiac arrest, triggers a cascade of brain damage. While immediate oxygen deprivation causes primary injury, a secondary phase of delayed neuronal death occurs in the days following the event, particularly in the cerebral cortex. Current clinical interventions to mitigate this secondary damage are limited. Calcitriol, known for its role in calcium homeostasis, also acts as a neuroprotective hormone through the Vitamin D receptor (VDR) expressed in the brain. This study explores whether post-ischemic administration of calcitriol can interrupt the apoptotic cascade and preserve neurological function.
Methodology
The study utilized a rat model of GCI induced by bilateral carotid artery ligation and hypotension. A total of 145 male Sprague Dawley rats were assigned to groups including Sham, GCI-only, and GCI treated with calcitriol (1 µg/kg). Researchers evaluated outcomes through neurological severity scores (NSS), brain water content, and 2,3,5-triphenyltetrazolium chloride (TTC) staining to measure infarct volume. Cellular and molecular changes were analyzed using Hematoxylin and Eosin (H&E) staining, Transmission Electron Microscopy (TEM), Western blotting, and immunofluorescence. To confirm the mechanism, the ERK1/2 inhibitor PD98059 was employed.
Results and Discussion
Reduction in Brain Tissue Damage
One of the most striking findings was the significant reduction in infarcted brain tissue following calcitriol treatment. TTC staining revealed that while GCI caused extensive tissue death, calcitriol administration significantly lowered the infarction ratio (P<0.005).
Cellular and Structural Preservation
Histopathological analysis via H&E staining showed that calcitriol treatment prevented the typical signs of neuronal damage seen after GCI, such as cell shrinkage and nuclear pyknosis. Furthermore, TEM imaging demonstrated that calcitriol preserved the ultrastructure of neurons, maintaining the integrity of nuclear membranes and mitochondria, which otherwise showed significant vacuolation and chromatin condensation in untreated GCI rats.
Functional Recovery and Molecular Mechanism
Functional assessments showed that calcitriol-treated rats had significantly lower neurological deficit scores starting from day 3 post-injury. Molecular analysis revealed that this protection is mediated by the VDR-ERK1/2 pathway. Calcitriol treatment increased VDR expression and ERK1/2 phosphorylation, which subsequently shifted the balance of apoptotic proteins: decreasing the "executioner" cleaved Caspase-3 and increasing the "survival" protein Bcl-2. The use of an ERK1/2 inhibitor (PD98059) effectively abolished these protective effects, confirming the pathway's essential role.
Conclusion
This study provides strong evidence that calcitriol exerts neuroprotective effects against GCI-induced damage. By activating the VDR and the ERK1/2 signaling pathway, calcitriol reduces brain edema, preserves neuronal structure, and improves functional outcomes. These results highlight Vitamin D receptor activation as a promising target for therapeutic intervention in ischemic brain injury.
Summary updated